Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 10 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

10%

1 trials in Phase 3/4

Results Transparency

20%

1 of 5 completed trials have results

Key Signals

5 recruiting1 with results

Enrollment Performance

Analytics

N/A

6(85.7%)

Phase 4

1(14.3%)

7Total

N/A(6)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (10)

Showing 10 of 10 trials

NCT07489274Phase 4Recruiting

Adjunctive Hyperbaric Oxygen Treatment for Patients With Necrotizing Soft-Tissue Infection (HOT-NSTI Trial).

Role: collaborator

NCT07357493Not ApplicableRecruiting

metaCARpal Bone Osteosynthesis Trail

Role: collaborator

NCT07440147Not ApplicableRecruiting

Effects of Akkermansia Muciniphila and Berberine Supplementation on Insulin Sensitivity in Night-shift Workers

Role: collaborator

NCT06288568Recruiting

Night Shift Work and Biomarkers of Obesity Risk in Hospital and Industry Workers

Role: collaborator

NCT05793554Recruiting

CLASSICA: Validating AI in Classifying Cancer in Real-Time Surgery

Role: collaborator

NCT04148508Not ApplicableCompleted

App-based Mental Health Promotion in Young European Adults

Role: collaborator

NCT05514886Completed

Evaluation of Molecular Point-of-care Xpert® Xpress SARS-CoV-2 Detection Implementation in Resource-limited Settings

Role: collaborator

NCT04633681Not ApplicableCompleted

Impact of Sweeteners on Behaviour, Physiology & Health

Role: collaborator

NCT02604316Not ApplicableCompleted

SATIN: Satiety Innovation. Study 2- University of Aberdeen

Role: collaborator

NCT01724411Not ApplicableCompleted

Satiety Innovation- Study 793. University of Aberdeen

Role: collaborator

All 10 trials loaded